Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6782220rdf:typepubmed:Citationlld:pubmed
pubmed-article:6782220lifeskim:mentionsumls-concept:C0021270lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C0020578lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C0040373lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C1135361lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:6782220lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:6782220pubmed:issue4lld:pubmed
pubmed-article:6782220pubmed:dateCreated1981-5-21lld:pubmed
pubmed-article:6782220pubmed:abstractTextWe studied the separate and combined effects of hyperventilation and administration of dopamine and tolazoline in five infants with pulmonary hypertension managed with indwelling pulmonary artery catheters. In five infants the right-to-left shunt reversed during ventilator-induced respiratory alkalosis (pH greater than 7.6). Response to drugs was variable and unpredictable. One infant could be oxygenated at normal pH during combined dopamine and tolazoline infusion. Other infants showed no response to drugs, or became worse during infusion. The ratio of pulmonary artery to systemic artery pressure averaged 1.14 with standard therapy, but decreased to 0.98 following respiratory alkalosis alone, to 0.87 following drug infusions, and to 0.70 following the combination of alkalosis and drug infusion. These changes were significant by analysis of variance at P less than 0.02, P less 0.001, and P less than 0.001, respectively. Systemic oxygenation was satisfactory in all cases when the pulmonary to systemic pressure ratio was less than 1.0.lld:pubmed
pubmed-article:6782220pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6782220pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6782220pubmed:languageenglld:pubmed
pubmed-article:6782220pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6782220pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6782220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6782220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6782220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6782220pubmed:statusMEDLINElld:pubmed
pubmed-article:6782220pubmed:monthAprlld:pubmed
pubmed-article:6782220pubmed:issn0022-3476lld:pubmed
pubmed-article:6782220pubmed:authorpubmed-author:HeymannM AMAlld:pubmed
pubmed-article:6782220pubmed:authorpubmed-author:GregoryG AGAlld:pubmed
pubmed-article:6782220pubmed:authorpubmed-author:DrummondW HWHlld:pubmed
pubmed-article:6782220pubmed:authorpubmed-author:PhibbsR ARAlld:pubmed
pubmed-article:6782220pubmed:issnTypePrintlld:pubmed
pubmed-article:6782220pubmed:volume98lld:pubmed
pubmed-article:6782220pubmed:ownerNLMlld:pubmed
pubmed-article:6782220pubmed:authorsCompleteYlld:pubmed
pubmed-article:6782220pubmed:pagination603-11lld:pubmed
pubmed-article:6782220pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:meshHeadingpubmed-meshheading:6782220-...lld:pubmed
pubmed-article:6782220pubmed:year1981lld:pubmed
pubmed-article:6782220pubmed:articleTitleThe independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension.lld:pubmed
pubmed-article:6782220pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6782220pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6782220lld:pubmed